Standout Papers

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Pr... 2004 2026 2011 2018 2.8k
  1. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer (2004)
    Daniel P. Petrylak, Catherine M. Tangen et al. New England Journal of Medicine
  2. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer (2015)
    Christopher J. Sweeney, Yu‐Hui Chen et al. New England Journal of Medicine
  3. Characterization of human plasma-derived exosomal RNAs by deep sequencing (2013)
    Xiaoyi Huang, Tiezheng Yuan et al. BMC Genomics
  4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial (2018)
    Christos E. Kyriakopoulos, Yu‐Hui Chen et al. Journal of Clinical Oncology

Immediate Impact

5 by Nobel laureates 7 from Science/Nature 131 standout
Sub-graph 1 of 16

Citing Papers

Prostate Cancer
2025 Standout
Enhancer selectivity in space and time: from enhancer–promoter interactions to promoter activation
2024 Standout
53 intermediate papers

Works of Manish Kohli being referenced

Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer
2016
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
and 8 more

Author Peers

Author Last Decade Papers Cites
Manish Kohli 6578 3411 3455 218 10.7k
William D. Figg 3722 2369 4544 233 10.1k
David F. Jarrard 4832 1963 3979 203 9.7k
William Kevin Kelly 6118 2011 4953 240 11.7k
Emmanuel S. Antonarakis 8617 3194 3734 494 12.6k
Kurt Miller 8902 3462 4529 350 14.4k
Mitchell C. Benson 8505 2165 3887 267 13.1k
Thomas W. Flaig 5042 1632 2042 207 7.7k
David M. Nanus 8050 3488 6088 326 14.4k
Glenn J. Bubley 7632 2719 3607 163 11.9k
Sabino De Placido 4412 3698 4332 376 13.7k

All Works

Loading papers...

Rankless by CCL
2026